25 studies found for: " May 06, 2009":" June 05, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Anal Cancer Screening Study
CyberSenga: Internet-based HIV Prevention in Uganda
Collecting and Storing Blood Samples From Patients With Cancer
† Indicates status has not been verified in more than two years